DX-3-235

N/A

Report date: 2026/01/13 17:57:00
NME

Base Information

Drug NameDX-3-235
Drug Alias NameDX3-235DX-3-235
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADH-ubiquinone oxidoreductase chain 1 inhibitors
TargetsNADH-ubiquinone oxidoreductase chain 1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A